Recombinant Human Erythropoietin Alfa from Canada
A biotechnologically produced hematopoietin stimulating red blood cell production, used in anemia treatment for chronic kidney disease patients. Classified in HTS 3002.90.52.50 as an immunological product (hematopoietin) for therapeutic use. It is a growth factor directly involved in blood cell regulation.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Submit purity assays and isoform profiles for FDA potency verification
• Package in pre-filled syringes with tamper-evident seals for import inspection
• Confirm not waste pharmaceuticals unfit for use per Chapter 30 note 6(k)